£

Our fundraising income

We're here for you if you want to talk

0808 2080 888

[email protected]

This year, we reached a total of £16.8 million through fundraising – well above the £15.3 million target we had set ourselves in this year of economic uncertainty and ongoing cost-of living crisis. Within our new five-year strategy, we’ve set a goal of increasing our total income to over £24 million by 2028-2029.

Our 2023-2024 Annual Report at a glance

A brightly-lit Walk of Light under the night sky.

Our Christmas campaign

Our integrated Christmas campaign has so far raised around £215,000 – over and above our £198,000 target. Our annual Notting Hill Carols by Candlelight Concert alone raised £46,000. And our appeal film outperformed previous video benchmarks on Meta, showing higher levels of engagement than in previous years.

Birmingham Walk of Light

Our Birmingham Walk of Light event in March 2024 saw over 2,000 supporters take part, raising £347,000. There were also 14 'DIY' community walks around the country, raising £12,429. The event was a great introduction for lots of new people to our community: 80% of those taking part had never taken part in a Blood Cancer UK event before. We’ll work to make sure we give them lots of reasons to stay involved with us.

Omaze Million Pound House Draw

In July, our teams worked closely together on the hugely successful Omaze Million Pound House Draw. The fact that the prize was a Yorkshire Farmhouse just felt right, given our connection to the ‘Calendar Girls’ – an amazing group of Yorkshire women who’ve to date raised over £6 million for blood cancer research.

The draw raised £1.95 million – almost double our first Omaze draw campaign (£1 million) – and this has funded six research projects.


Our 2023-2024 Annual Report at a glance

Ride London 2022

Fundraising events and challenges

Do something amazing and help us fund life-changing blood cancer research. Whether you take part in an existing event or challenge or fundraise in your own way, it all helps us reach our goal of beating blood cancer.

More About This